Hyman Charles D Baxter International Inc Transaction History

Hyman Charles D

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$76.85 - $89.45 $34,582 - $40,252	-450 Reduced 10.5%	3,835 $297,000
Q4 2020 Feb 08, 2021	SELL	$75.39 - $82.36 $150,780 - $164,720	-2,000 Reduced 31.82%	4,285 $344,000
Q3 2020 Oct 26, 2020	SELL	$78.33 - $90.73 $5,013 - $5,806	-64 Reduced 1.01%	6,285 $505,000
Q1 2020 Apr 30, 2020	SELL	$71.57 - $93.3 $7,156 - $9,330	-100 Reduced 1.55%	6,349 $515,000
Q4 2019 Feb 03, 2020	BUY	$76.7 - $88.45 $1,840 - $2,122	24 Added 0.37%	6,449 $539,000
Q2 2019 Jul 24, 2019	BUY	$73.44 - $82.41 $117,871 - $132,268	1,605 Added 33.3%	6,425 $526,000
Q1 2019 May 13, 2019	BUY	$64.48 - $81.31 $29,016 - $36,589	450 Added 10.3%	4,820 $392,000
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $21,212 - $23,325	-300 Reduced 6.42%	4,370 $337,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,670	4,670 $283,000

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.3B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

Stay updated on Hyman Charles D with notifications on news.